BMS-986322

DRUG6 trials

Sponsors

Bristol-Myers Squibb

Conditions

Healthy Male ParticipantsHealthy ParticipantsPsoriasis

Phase 1

A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants

CompletedNCT04175925

Bristol-Myers SquibbHealthy Participants

Start: 2019-11-15End: 2021-07-13Updated: 2022-05-31

A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent

CompletedNCT05546151

Bristol-Myers SquibbHealthy Participants

Start: 2022-09-28End: 2023-04-07Updated: 2023-06-22

A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estradiol [EE]/Norethindrone [NET]) in Healthy Female Participants

CompletedNCT05579574

Bristol-Myers SquibbHealthy Participants

Start: 2022-10-21End: 2023-06-01Updated: 2023-08-18

A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants

CompletedNCT05615012

Bristol-Myers SquibbHealthy Participants

Start: 2022-11-11End: 2023-12-13Updated: 2024-03-27

A Study to Evaluate the Drug Levels, Metabolism, and Removal of BMS-986322 in Healthy Adult Male Participants

CompletedNCT06088264

Bristol-Myers SquibbHealthy Male Participants

Start: 2023-10-31End: 2023-12-22Updated: 2024-03-29

Phase 2

A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

CompletedNCT05730725

Bristol-Myers SquibbPsoriasis

Start: 2023-04-03End: 2024-08-06Updated: 2025-11-25